Latest DOCN Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Miller Jump | Truist | Maintains | Buy | - | |
| Zacks Equity Research | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Kingsley Crane | Canaccord Genuity | Reiterates | Buy | $200.00 | |
| Gabriela Borges | Goldman Sachs | Maintains | Buy | $179.00 → $178.00 −1.00 (−0.6%) | |
| Raimo Lenschow | Barclays | Maintains | Buy | $160.00 → $161.00 +1.00 (+0.6%) | |
| Radi Sultan | UBS | Maintains | Hold | $155.00 → $140.00 −15.00 (−9.7%) | |
| Mark Zhang | Citi | Maintains | Buy | $185.00 → $190.00 +5.00 (+2.7%) | |
| Param Singh | Oppenheimer | Reiterates | Buy | $190.00 | |
| Mike Cikos | Needham | Maintains | Hold | - | |
| Sanjit Singh | Morgan Stanley | Reiterates | Buy | $175.00 | |
| Jason Ader | William Blair | Maintains | Buy | - | |
| Gabriela Borges | Goldman Sachs | Maintains | Buy | $179.00 → $178.00 −1.00 (−0.6%) | |
| Wamsi Mohan | BofA Securities | Reiterates | Buy | $200.00 | |
| Sanjit Singh | Morgan Stanley | Reiterates | Buy | $175.00 | |
| Brad Reback | Stifel Nicolaus | Downgrades | Buy | $135.00 → $160.00 +25.00 (+18.5%) | |
| Robert Oliver | Baird | Initiates | Buy | $165.00 | |
| Nauman Khan | InvestorPlace | Initiates Coverage | Buy | - |
